158 related articles for article (PubMed ID: 30968599)
1. HDAC4 mutations cause diabetes and induce β-cell FoxO1 nuclear exclusion.
Gong M; Yu Y; Liang L; Vuralli D; Froehler S; Kuehnen P; Du Bois P; Zhang J; Cao A; Liu Y; Hussain K; Fielitz J; Jia S; Chen W; Raile K
Mol Genet Genomic Med; 2019 May; 7(5):e602. PubMed ID: 30968599
[TBL] [Abstract][Full Text] [Related]
2. Repression of Transcriptional Activity of Forkhead Box O1 by Histone Deacetylase Inhibitors Ameliorates Hyperglycemia in Type 2 Diabetic Rats.
Cho HM; Seok YM; Lee HA; Song M; Kim I
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30424007
[TBL] [Abstract][Full Text] [Related]
3. Specific control of pancreatic endocrine β- and δ-cell mass by class IIa histone deacetylases HDAC4, HDAC5, and HDAC9.
Lenoir O; Flosseau K; Ma FX; Blondeau B; Mai A; Bassel-Duby R; Ravassard P; Olson EN; Haumaitre C; Scharfmann R
Diabetes; 2011 Nov; 60(11):2861-71. PubMed ID: 21953612
[TBL] [Abstract][Full Text] [Related]
4. Insulin secretion impairment in Sirt6 knockout pancreatic β cells is mediated by suppression of the FoxO1-Pdx1-Glut2 pathway.
Song MY; Wang J; Ka SO; Bae EJ; Park BH
Sci Rep; 2016 Jul; 6():30321. PubMed ID: 27457971
[TBL] [Abstract][Full Text] [Related]
5. An inhibitor-mediated beta-cell dedifferentiation model reveals distinct roles for FoxO1 in glucagon repression and insulin maturation.
Casteels T; Zhang Y; Frogne T; Sturtzel C; Lardeau CH; Sen I; Liu X; Hong S; Pauler FM; Penz T; Brandstetter M; Barbieux C; Berishvili E; Heuser T; Bock C; Riedel CG; Meyer D; Distel M; Hecksher-Sørensen J; Li J; Kubicek S
Mol Metab; 2021 Dec; 54():101329. PubMed ID: 34454092
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-96 regulates pancreatic β cell function under the pathological condition of diabetes mellitus through targeting Foxo1 and Sox6.
Qi H; Yao L; Liu Q
Biochem Biophys Res Commun; 2019 Nov; 519(2):294-301. PubMed ID: 31506178
[TBL] [Abstract][Full Text] [Related]
7. Forkhead box O1/pancreatic and duodenal homeobox 1 intracellular translocation is regulated by c-Jun N-terminal kinase and involved in prostaglandin E2-induced pancreatic beta-cell dysfunction.
Meng Z; Lv J; Luo Y; Lin Y; Zhu Y; Nie J; Yang T; Sun Y; Han X
Endocrinology; 2009 Dec; 150(12):5284-93. PubMed ID: 19837872
[TBL] [Abstract][Full Text] [Related]
8. PRMT1 promotes glucose toxicity-induced β cell dysfunction by regulating the nucleo-cytoplasmic trafficking of PDX-1 in a FOXO1-dependent manner in INS-1 cells.
Lv L; Chen H; Sun J; Lu D; Chen C; Liu D
Endocrine; 2015 Aug; 49(3):669-82. PubMed ID: 25874535
[TBL] [Abstract][Full Text] [Related]
9. Forkhead Box Protein 1 (FoxO1) Inhibits Accelerated β Cell Aging in Pancreas-specific SMAD7 Mutant Mice.
Xiao X; Chen C; Guo P; Zhang T; Fischbach S; Fusco J; Shiota C; Prasadan K; Dong H; Gittes GK
J Biol Chem; 2017 Feb; 292(8):3456-3465. PubMed ID: 28057752
[TBL] [Abstract][Full Text] [Related]
10. Nuclear Export of FoxO1 Is Associated with ERK Signaling in β-Cells Lacking Insulin Receptors.
Mezza T; Shirakawa J; Martinez R; Hu J; Giaccari A; Kulkarni RN
J Biol Chem; 2016 Oct; 291(41):21485-21495. PubMed ID: 27535223
[TBL] [Abstract][Full Text] [Related]
11. FoxO1 Deacetylation Decreases Fatty Acid Oxidation in β-Cells and Sustains Insulin Secretion in Diabetes.
Kim-Muller JY; Kim YJ; Fan J; Zhao S; Banks AS; Prentki M; Accili D
J Biol Chem; 2016 May; 291(19):10162-72. PubMed ID: 26984405
[TBL] [Abstract][Full Text] [Related]
12. The vitamin D receptor (VDR) protects pancreatic beta cells against Forkhead box class O1 (FOXO1)-induced mitochondrial dysfunction and cell apoptosis.
Chen C; Luo Y; Su Y; Teng L
Biomed Pharmacother; 2019 Sep; 117():109170. PubMed ID: 31261027
[TBL] [Abstract][Full Text] [Related]
13. Oleic acid increases the transcriptional activity of FoxO1 by promoting its nuclear translocation and β-catenin binding in pancreatic β-cells.
Jazurek-Ciesiolka M; Janikiewicz J; Dobrzyn P; Dziewulska A; Kozinski K; Dobrzyn A
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2753-2764. PubMed ID: 31255704
[TBL] [Abstract][Full Text] [Related]
14. Glucose regulates Foxo1 through insulin receptor signaling in the pancreatic islet beta-cell.
Martinez SC; Cras-Méneur C; Bernal-Mizrachi E; Permutt MA
Diabetes; 2006 Jun; 55(6):1581-91. PubMed ID: 16731820
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Foxo1-regulated genes using Foxo1-deficient pancreatic β cells.
Miyazaki S; Minamida R; Furuyama T; Tashiro F; Yamato E; Inagaki S; Miyazaki J
Genes Cells; 2012 Sep; 17(9):758-67. PubMed ID: 22845550
[TBL] [Abstract][Full Text] [Related]
16. 1,25D/VDR inhibits pancreatic β cell ferroptosis by downregulating FOXO1 expression in diabetes mellitus.
Ding Y; Wu Q
Cell Signal; 2023 May; 105():110564. PubMed ID: 36581217
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic-β-cell survival and proliferation are promoted by protein kinase G type Iα and downstream regulation of AKT/FOXO1.
Wong JC; Vo V; Gorjala P; Fiscus RR
Diab Vasc Dis Res; 2017 Sep; 14(5):434-449. PubMed ID: 28631500
[TBL] [Abstract][Full Text] [Related]
18. FoxO1 inhibition promotes differentiation of human embryonic stem cells into insulin producing cells.
Yu F; Wei R; Yang J; Liu J; Yang K; Wang H; Mu Y; Hong T
Exp Cell Res; 2018 Jan; 362(1):227-234. PubMed ID: 29157981
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Foxo1 mediates protective effects of ghrelin against lipotoxicity in MIN6 pancreatic beta-cells.
Wang W; Liu Y; Chen Y; Cao C; Xiang Y; Zhang D; Han L; Zhao H; Liu G
Peptides; 2010 Feb; 31(2):307-14. PubMed ID: 19944124
[TBL] [Abstract][Full Text] [Related]
20. Identification of
Kuo T; Kraakman MJ; Damle M; Gill R; Lazar MA; Accili D
Proc Natl Acad Sci U S A; 2019 Oct; 116(40):20033-20042. PubMed ID: 31527256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
